Benefits of Effexor Lawsuit Funding
Children who suffer birth defects from antidepressants can face years of medical treatment and monitoring, and an equally long time waiting for their lawsuits to resolve. Effexor is just one of many popular antidepressants that has been blamed for congenital birth defects when taken during pregnancy. But Effexor lawsuit funding can provide financial relief now instead of years down the road. At LawStreet Capital, we can buy you time to pursue your case with a risk-free settlement loan.
The drug companies can drag product liability cases out for years in hopes that it will compel desperate plaintiffs to settle for less than they deserve. But an antidepressant birth defect settlement loan takes the power out of the drug makers’ hands by giving you financial flexibility. Once your application is approved, your settlement loan can be in your account in as little as 24 hours.
Advantages of Effexor lawsuit funding
If you work with a product liability lawyer, you may not have to pay legal fees up front, but you may need to pay court expenses, witness fees, and plenty of other litigation expenses that you may not have considered. On top of that, medical bills pile up and household income can suffer when the legal proceedings and medical care interfere with employment. With help like Effexor lawsuit funding, you can stop this train before it derails.
By relieving the immediate pressures of financial stress, your attorney can focus on fighting for the full compensation you may be entitled to receive.
Status of antidepressant birth defect lawsuits
Antidepressant birth defect lawsuits are based on similar allegations – that the manufacturers failed to thoroughly research the effect of using the antidepressants during pregnancy and failed to inform consumers and physicians of the risks. The types of antidepressants involved in the lawsuits, like Effexor, Zoloft, Paxil, and Lexapro, are SSRIs and SSNRIs – they face similar risks and allegations, as well as similar litigation paths rife with delays while plaintiffs wait for compensation.
Federal Effexor lawsuits have been combined in multidistrict litigation in the Eastern District of Pennsylvania, before Judge Cynthia M. Rufe. There are nearly 100 member cases in the Effexor MDL. Some experts expect that several hundred cases will ultimately be filed. In the Effexor MDL, Judge Rufe recently filed a case management order authorizing plaintiffs to directly file their complaints in the Eastern District of Pennsylvania. This is expected to make case filing quicker and less duplicative by no longer requiring a plaintiff to first file in the federal court in his or her own state and then petition to have the case transferred to the MDL. But it also means that the cases will follow the same schedule and the very first lawsuits will not face trial until November 2015.
Judge Rufe is also overseeing the hundreds of antidepressant birth defects lawsuits pending in a Zoloft MDL. The Zoloft proceedings are further along than the Effexor MDL – the first Zoloft trials are expected to begin in January 2015. But typically not all cases are tried at once so many Zoloft plaintiffs may still have many months after that to wait for trial date.
Free application for a risk-free settlement loan
If you have a current case pending and would like to learn more about lawsuit funding for your Effexor birth defects claim, please call LawStreet Capital today for a no-obligation discussion with one of our representatives. The application is free, and there is no obligation to repay the funds unless you win compensation. Call toll-free at 1-866-FUND-662.
